Enovis (NYSE:ENOV) Hits New 12-Month Low Following Analyst DowngradeMarket Beat·1 day ago, 03:20 PMENOV-2.99%
Analyst Reiterates Buy on Enovis, Maintains $52 Price Target Following Strategic eCential Robotics AcquisitionTip Ranks·2 days ago, 08:35 PMENOV-2.99%
Enovis: Buy Rating Reaffirmed as Surgical Robotics Acquisition Closes Competitive Gap; Price Target Trimmed to $36 on Deal-Related Costs and LeverageTip Ranks·2 days ago, 07:05 PMENOV-2.99%
ENOV: Acquisition of eCential Robotics boosts robotics innovation and growth in orthopedicsQuartr·Sep 1 at 06:05 PMENOV-2.99%
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics DealMarket Beat·Sep 1 at 02:03 PMENOV-2.99%
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics | ENOV Stock NewsStockTitan·Sep 1 at 02:30 AMENOV-2.99%
ENOV: Acquisition of a surgical robotics leader for up to €211M to boost innovation and market reachQuartr·Sep 1 at 10:39 AMENOV-2.99%
